Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad

BACKGROUND & OBJECTIVES: Multidrug resistant methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of nosocomial and community acquired infections and is on the rise. The glycopeptide vancomycin has been proposed as the drug of choice for treating such infections. The present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Thati, Venubabu, Shivannavar, Channappa T., Gaddad, Subhaschandra M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249970/
https://www.ncbi.nlm.nih.gov/pubmed/22199111
http://dx.doi.org/10.4103/0971-5916.91001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249970/
https://www.ncbi.nlm.nih.gov/pubmed/22199111
http://dx.doi.org/10.4103/0971-5916.91001

Ejemplares similares